Canadian Clinical Stage Biopharmaceutical Company
Canadian Clinical Stage Biopharmaceutical Company

Canadian Clinical Stage Biopharmaceutical Company

AllVideosLiveAbout
    Upside potential of early stage Biotech investing
    9:45

    Upside potential of early stage Biotech investing

    ImmuniMed Inc CEO, John Hare speaks with Dr. Tracy Gilson on why she invested in the initial seed round and overall expectations.